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Abstract
Background: The effects of postal questionnaire burden on return rates and answers given are unclear following
treatment on an intensive care unit (ICU). We aimed to establish the effects of different postal questionnaire
burdens on return rates and answers given.
Methods: Design: A parallel group randomised controlled trial. We assigned patients by computer-based
randomisation to one of two questionnaire packs (Group A and Group B).
Setting: Patients from 26 ICUs in the United Kingdom.
Inclusion criteria: Patients who had received at least 24 h of level 3 care and were 16 years of age or older.
Patients did not know that there were different questionnaire burdens. The study included 18,490 patients.
12,170 were eligible to be sent a questionnaire pack at 3 months. We sent 12,105 questionnaires (6112 to
group A and 5993 to group B).
Interventions: The Group A pack contained demographic and EuroQol group 5 Dimensions 3 level (EQ-5D-3 L)
questionnaires, making four questionnaire pages. The Group B pack also contained the Hospital Anxiety and
Depression Score (HADS) and the Post-Traumatic Stress Disorder Check List-Civilian (PCL-C) questionnaires,
making eight questionnaire pages in total.
Main outcome measure: Questionnaire return rate 3 months after ICU discharge by group.
Results: In group A, 2466/6112 (40.3%) participants responded at 3 months. In group B 2315/ 5993 (38.6%)
participants responded (difference 1.7% CI for difference 0–3.5% p = 0.053).
Group A reported better functionality than group B in the EQ-5D-3 L mobility (41% versus 37% reporting no
problems p = 0.003) and anxiety/depression (59% versus 55% reporting no problems p = 0.017) domains.
Conclusions: In survivors of intensive care, questionnaire burden had no effect on return rates. However,
questionnaire burden affected answers to the same questionnaire (EQ-5D-3 L).
Trial registration: ISRCTN69112866 (assigned 02/05/2006).
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Background
Self-completed postal questionnaires provide a conveni-
ent, cost-effective method of measuring patient outcomes,
avoiding travel for participants and researchers. However,
non-participation has been increasing over time [1]. If
non-participation is not random, the sampled population
may differ from the whole population and may affect the
generalisability and usefulness of the results [2].
Many researchers have investigated methods of
improving responses to postal questionnaires. Their
findings have been extensively reviewed [3–6]. Varied
methods such as using a package of communication
strategies, teasers on envelopes, personalising the ques-
tionnaire, non-monetary incentives and making clear that
the study is based at a university have all been found to
improve response rates [5]. Questionnaire burden may
affect participation in self-completed postal questionnaires
[5, 6]. It may also alter the answers given [7].
Changes in quality of life, mental and physical health
occur after treatment on an Intensive Care Unit (ICU)
[8–12]. In the Intensive Care Outcome Network (ICON)
study we investigated quality of life, mental and physical
health following treatment on an ICU using validated
postal questionnaires. Whether questionnaire burden
affects return rates or answers from patients after treat-
ment on an ICU is unknown. In other hospitalised patient
populations, we found two randomised studies, with con-
flicting results [7, 13].
We therefore undertook an early example of a Study
Within a Trial (SWAT) [14] to investigate the effects of
questionnaire burden on participation and answers.
Methods
Study design
We conducted a randomised controlled trial as a study
within a trial (SWAT), within the ICON study. The
ICON study assessed quality of life, the incidence of
depression, and the incidence of post-traumatic stress
disorder following at least 24 h treatment on an ICU;
the protocol has been published [15]. The study received
national ethics approval (REC 06/Q1605/17) and local re-
search governance approval was obtained at each centre.
Study population
Patients from 26 UK ICUs took part (1 university hospital,
6 university-affiliated hospitals and 19 district general
hospitals). We gave all patients a letter introducing the
study at ICU discharge: it explained that they might
receive mail from the study team. Patients were eligible if
they received level 3 care (as defined by the Intensive Care
Society, London [16]) on an ICU for at least 24 h. We
excluded patients if they were under 16 years old. We also
excluded patients not registered with a general practi-
tioner or of no fixed abode (factors anticipated to prevent
follow-up in the study). We excluded patients taking part
in another questionnaire follow-up study run by the same
research office.
Allocation
We used a pseudo-random number generator, built into
GNU Libc (http://www.gnu.org/software/libc/), to allocate
patients to a study group without restriction. Allocation
occurred at the central research office at the point of
enrolment.
Interventions
The group A pack contained four questionnaire pages.
The pack contained the one page EuroQol 5 dimensions
3 level (EQ-5D-3 L) questionnaire, two pages each con-
taining a single visual analogue scale and a single page
demographics questionnaire.
The group B pack contained eight questionnaire pages.
In addition to the group A pack, it also contained a two
page Hospital Anxiety and Depression Scale (HADS)
questionnaire and a two page Post-traumatic stress dis-
order Check List– Civilian version (PCL-C) questionnaire.
(For example questionnaire packs, see see Additional files
1 and 2 respectively.
The initial packs sent at 3 months contained a personally
addressed letter inviting participation. The 3-month packs
also contained a three-page study information leaflet and a
consent form (required by the Ethics Committee).
Packs at 12 and 24 months contained a covering letter
and the questionnaires, but no information leaflet or
consent form. However, if patients did not receive a 3-
month pack because they remained in hospital, the
12-month pack contained the initial letter, study infor-
mation leaflet and consent form. Questionnaire con-
tent remained the same at 3, 12 and 24 months.
Participants were unaware that we were sending differ-
ent questionnaire packs.
Survey implementation
Both groups received questionnaire packs 3 months after
ICU discharge. We sent further questionnaire packs at 12
and 24 months after ICU discharge to respondents who
agreed to take part further. We sent repeat questionnaire
packs if a reply did not arrive after 2 weeks. Repeat ques-
tionnaire packs were identical to the first pack other than
slight changes to the wording of the letter that made it
clear that this was a repeat mailing. We did not contact
patients who spent over 75 days in hospital following their
discharge from ICU at 3 months, instead these patients
were first contacted at 12 months. Patients who remained
in hospital at 12 months did not receive any follow up.
We checked survival with the patient’s registered gen-
eral practitioner and the National Health Service clinical
spine application before posting each questionnaire
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pack. If the general practitioner informed us that a par-
ticipant would be unable to complete a questionnaire,
we did not send a pack.
We printed all documents using a high quality laser
printer. We printed the invitation letter on Oxford
University headed paper. The trial coordinator signed each
letter. We printed each questionnaire on different coloured
paper and bound them with a removable clip. All pages
were single-sided and numbered. We used uniform design,
large font size and generous spacing. All packs contained a
Freepost addressed envelope for questionnaire return. All
packs included an ICON branded pen with an ICON-
labelled tea bag as incentives; the tea bag label invited the
participant to enjoy a cup of tea whilst completing the
questionnaire. Participants could also complete the ques-
tionnaires by telephone with a trained researcher.
Outcome measures
The primary outcome measure was the questionnaire
return rate 3 months after ICU discharge, by group. For
the first mailed pack we defined questionnaire return as
a completed consent form agreeing to take part in the
study and at least one questionnaire question or visual
analogue scale completed and returned. For subsequent
packs we defined questionnaire return as at least one
questionnaire question or visual analogue scale com-
pleted and returned.
Secondary outcome measures were return rates at 12
and 24 months and the effect of questionnaire burden
on the EQ-5D-3 L weighted index score and individual
domain scores at 3 months after ICU discharge. We de-
fined a valid response as completion of all questions
within an instrument. We undertook a post-hoc analysis
of missingness on the invalid returns.
Sample size
The ICON study ran for 19 months before the rando-
mised controlled trial started. During this time we sent
6028 patients the group B pack and a Short Form 36
version 2 (SF36v2—health related quality of life question-
naire) at 3 months. The 3 month questionnaire return rate
was 36%. We assumed a similar return rate for group B
packs sent in the trial. We estimated 18,000 patients
would take part in the next 28 months (allowing for site
changes). Assuming a similar mortality 75 days following
discharge from ICU (32%), power of 90% and a signifi-
cance level of 0.05, this sample size was sufficient to detect
a 2.9% change in the return rate.
Statistical analysis
We used an electronic form reader (Teleform v10,
Cambridge, UK) to transcribe questionnaire responses into
a database (MySQL v5.0-Oracle Corporation, Redwood
Shores, CA). Study office personnel manually entered data
that the electronic form reader could not interpret. We
linked participant records with the Intensive Care National
Audit & Research Centre (ICNARC) Case Mix Programme
database to obtain admitting diagnoses and severity of
illness scores [17].
Statistical analysis was undertaken using R Core v3.2.3
[18]. We used Fisher’s exact test to compare between
group rates of questionnaire return. We analysed ques-
tionnaire return rates for all patients to whom we sent a
questionnaire. We used the Mann–Whitney “U” test to
compare EQ-5D-3 L weighted index scores and visual
analogue scales between groups at the first time point.
We used the Chi-squared test to compare the propor-
tion of patients who responded as EQ-5D-3 L level 1
(“No problems”) with a single collapsed category for
those who responded as level 2 (“moderate”) or level 3
(“severe”) [19]. We did not correct for multiple testing.
We did not include information from EQ-5D-3 L respon-
dents with any missing or invalid domain responses in our
analysis of responses to the EQ-5D-3 L questionnaire.
Results
Patients joined the study May 2008-September 2010 inclu-
sive as planned. The study database closed 28 months after
recruitment of the final patient. Of the 18,490 patients who
were screened, 18,134 underwent randomization (Fig. 1).
Table 1 shows the characteristics of randomised patients by
group. Table 2 is a response analysis showing the character-
istics of those patients that responded to the study at
3 months (an equivalent non-response analysis is included
in Additional file 3: Table S1). Table 3 shows response rates
at 3, 12 and 24 months by group. Response rates were
equivalent at all time points.
We randomised 18,134 of the 18,490 patients assessed
for inclusion (see Fig. 1). 5410 patients died within
3 months of ICU discharge. We delayed follow-up until
12 months in 554 patients who spent over 75 days in hos-
pital. 12,170 patients were eligible to receive a question-
naire pack at 3 months. Table 1 shows demographic data
for all participants. Table 2 is a response analysis showing
the characteristics of those patients that responded to the
study at 3 months (an equivalent non-response analysis is
included in Additional file 3: Table S1). Between the two
groups responders were very similar, although, without
correction for multiple testing, differences existed in self-
reported university education and need for assistance.
Table 3 shows response rates at 3, 12 and 24 months by
group. Response rates were equivalent at all time points.
Table 4 shows valid responses to the EQ-5D-3 L ques-
tionnaire at 3 months by group. Patients in group B re-
ported worse function in the “anxiety and depression”
(p = 0.017) and “mobility” (p = 0.003) domains of the
EQ-5D-3 L questionnaire at 3 months. Questionnaire
burden did not affect answers to the “activities”, “pain/
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discomfort” and “self-care” domains at 3 months. Nor
did it affect median EQ-5D-3 L weighted index scores or
EQ visual analogue scale score at 3 months. Participants
did not always complete every dimension. An analysis of
missingness is shown in Additional file 4: Table S2.
Discussion
Halving the questionnaire burden had no effect on
response rates. Most participants who returned a
questionnaire at 3 months completed questionnaires at
later follow-up points. The group sent the long question-
naire pack reported worse function in the “mobility” and
“anxiety and depression” EQ-5D-3 L domains.
We believe our study is by far the largest randomised
controlled trial of questionnaire burden. Our short
questionnaire pack was the EQ-5D-3 L (four pages).
The EQ-5D-3 L was the shortest validated quality of
life questionnaire for patients recovering from critical
Fig. 1 Consort diagram
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illnesses. Our long questionnaire pack also contained
HADS and PCL-C questionnaires (an extra four
pages).
We believe we followed best practice for postal ques-
tionnaires [3, 5, 6, 20]. Packs included an ICON branded
pen and teabag as non-monetary incentives. We used a
non-financial incentive appropriate to the situation as
these have evidence of benefit and because a financial
incentive would have been too costly given the scale of
our study [5, 21]. We used personalised letters headed
on University of Oxford paper that detailed the patients
name, address and their admission hospital [3, 5]. We
printed each questionnaire on different coloured paper
bound with a removable clip [5]. We used a package of
postal communications, including sending out 2 copies
of the questionnaires [3]. We used good data manage-
ment practices to optimise our data capture. This
included using only single-sided pages to ensure par-
ticipants did not miss questions printed on the back of
pages and numbering the pages [5]. We used a large
font size and generous spacing to facilitate responses
from older patients [22].
Our study has limitations. We only contacted patients
by post, limiting our findings to postal-only question-
naires. We stopped sending questionnaires to patients
who did not respond at the previous mailing point,
however recovery from critical illness may have in-
creased responses over time. Additional telephone con-
tact may have changed our results, although this took
place very rarely. Our short questionnaire pack con-
tained nine pages. Five of these pages were the letter,
consent form and information leaflet. These pages were
necessary as patients did not agree to take part before leav-
ing hospital. Informed consent before discharge would have
been a more complex approach. However, a (shorter) pack
without these pages may have improved return rates [5].
Two studies have examined the effect of questionnaire
burden in patients discharged from hospital [7, 13]. In the
International Stroke trial more participants responded to
a six question EuroQol instrument than the longer SF-36
questionnaire [7]. Yet, this difference was not seen
with Picker Patient Experience questionnaires of dif-
ferent lengths [13].
Three systematic reviews have assessed the effect of
reducing questionnaire burden on return rates [3, 5, 6].
They all included participants who had not recently been
in hospital. Two report an increase in return rates with
decreased questionnaire burden [5, 6]. The most recent,
restricted to clinical randomised controlled trials found
only a marginal effect [3]. In patients recovering from
severe illness, return rates to postal questionnaires are
variable [7–12].
Table 1 Demographics
Group A (n = 9132) Group B (n = 9002) All (n = 18,134)
Age
median, [IQR]
66 [52–76] 67 [53–76] 66 [52–76]
Male sex (%) 56% 56% 56%
APACHE II score
median, [IQR]
16 [12–21] 16 [12–21] 16 [12–21]
ICU length of stay days median [IQR] 3 [2–7] 3 [2–6] 3 [2–7]
Hospital length of stay days median
[IQR]
14 [7–27] 14 [7–28] 14 [7–28]
Reason for ICU admission n (%)
Respiratory tract infection 966 (11) 972 (11) 1938 (11)
Major vascular procedure 453 (5) 428 (5) 881 (5)
Large bowel tumour 383 (4) 454 (5) 837 (5)
Acute renal failure 439 (5) 420 (5) 859 (5)
Chronic obstructive pulmonary disease 283 (3) 292 (3) 575 (3)
Bowel perforation 278 (3) 226 (3) 504 (3)
Septicaemia/septic shock 304 (3) 300 (3) 604 (3)
Oesophageal neoplasm 130 (1) 136 (2) 266 (1)
Status epilepticus 198 (2) 174 (2) 372 (2)
Self-poisoning 290 (3) 291 (3) 581 (3)
Not recorded 301 (3) 309 (3) 610 (3)
Other 5107 (56) 5000 (56) 10,107 (56)
n (%), median [interquartile range]
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Table 2 Responders at 3 months
Group A (n = 2466) Group B (n = 2315) p All (n = 4781)
Age median, [IQR] 65 [53–74] 65 [53–74] 0.99c 65 [53–74]
Male sex (%) 57% 57% 0.87b 57%
APACHE II score median, [IQR] 15 [11–19] 14 [11–19] 0.08a 15 [11–19]
ICU length of stay days median [IQR] 3 [2–6] 3 [2–6] 0.33a 3 [2–6]
Hospital length of stay days median [IQR] 15 [9–26] 15 [8–25] 0.23a 15 [8–25]
Reason for ICU admission n (%)
Respiratory tract infection 237 (10) 192 (8) 0.16b 429 (9)
Major vascular procedure 185 (8) 171 (7) 0.93b 356 (7)
Large bowel tumour 148 (6) 173 (7) 0.07b 321 (7)
Acute renal failure 109 (4) 90 (4) 0.42b 199 (4)
Chronic obstructive pulmonary disease 79 (3) 76 (3) 0.95b 155 (3)
Bowel perforation 66 (3) 47 (2) 0.18b 113 (2)
Septicaemia/septic shock 60 (2) 61 (3) 0.73b 121 (3)
Oesophageal neoplasm 56 (2) 70 (3) 0.14b 126 (3)
Status epilepticus 52 (2) 44 (2) 0.69b 96 (2)
Self-poisoning 44 (2) 53 (2) 0.27b 97 (2)
Not recorded 77 (3) 64 (3) 0.53b 141 (3)
Other 1353 (55) 1274 (55) 2627 (55)
Self-reported demographics n (%)
Current address Usual address 2305 (93) 2165 (94) 4470 (93)
Family 36 (1) 38 (2) 74 (2)
Rehabilitation 19 (1) 11 (0) 30 (1)
Other 36 (1) 38 (2) 74 (2)
Not usual (unspecified) 13 (1) 10 (0) 23 (0)
Missing 57 (2) 53 (2) 0.79b 110 (2)
Higher education Yes 985 (40) 983 (42) 1968 (41)
No 1235 (50) 1138 (49) 2373 (50)
Missing 246 (10) 194 (8) 0.07b 440 (9)
University degree Yes 580 (24) 600 (26) 1180 (25)
No 1700 (69) 1579 (68) 3279 (69)
Missing 186 (8) 136 (6) 0.02b 322 (7)
Current employment status Full time 245 (10) 213 (9) 458 (10)
Part time 108 (4) 129 (6) 237 (5)
Seeking 27 (1) 35 (2) 62 (1)
Retired 1353 (55) 1250 (54) 2603 (54)
Sick 380 (15) 376 (16) 756 (16)
Housework 120 (5) 110 (5) 230 (5)
Student 24 (1) 17 (1) 41 (1)
Other 112 (5) 97 (4) 209 (4)
Missing 97 (4) 88 (4) 0.47b 185 (4)
Prior employment status Full time 437 (18) 388 (17) 825 (17)
Part time 189 (8) 190 (8) 379 (8)
Seeking 38 (2) 24 (1) 62 (1)
Retired 1233 (50) 1170 (51) 2403 (50)
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In the International Stroke Trial [7], where return rates
were higher than in our study, patients agreed to take part
in the trial before they received questionnaires. In the
ICON study, we combined agreeing to take part and
returning the first questionnaire. This combination may
explain our lower initial return rates. Where patients
agreed to take part in our study, later return rates were
similarly high. In our study the longer questionnaire group
reported worse function in the “mobility” and “usual activ-
ities” EQ-5D-3 L domains.
Two trials in recently hospitalised patients also studied
the relationship between questionnaire burden and the
answers given. Different Picker Patient Experience ques-
tionnaire lengths did not affect the answers given [13].
Conversely, more stroke survivors scored themselves as
dependent using the (shorter) six question EuroQol instru-
ment than the SF-36 instrument [7]. The difference seen
may reflect the different questionnaires used, rather than the
questionnaire burden. In our study, questionnaire burden af-
fected the answers given to the EQ-5D-3 L questionnaire.
When presented with additional questionnaires four percent
of respondents placed themselves in a worse category.
In patients discharged from an ICU, our study is large
enough to be definitive. Reducing questionnaire length
from eight to four pages has little effect on return rates.
However, including extra questionnaires resulted in differ-
ent EQ-5D-3 L answers. This interaction suggests investi-
gators should avoid mailings with multiple questionnaires.
The effect adds to the case for minimising the burden to
participants.
Table 2 Responders at 3 months (Continued)
Sick 168 (7) 169 (7) 337 (7)
Housework 132 (5) 105 (5) 237 (5)
Student 27 (1) 16 (1) 43 (1)
Other 75 (3) 87 (4) 162 (3)
Missing 167 (7) 166 (7) 0.28b 333 (7)
Carer now Yes 150 (6) 152 (7) 302 (6)
No 2207 (89) 2052 (89) 4259 (89)
Missing 109 (4) 111 (5) 0.64b 220 (5)
Carer prior Yes 159 (6) 170 (7) 329 (7)
No 1844 (75) 1680 (73) 3524 (74)
Missing 463 (19) 465 (20) 0.2b 928 (19)
Assistance Answered 246 (10) 288 (12) 534 (11)
Unable 68 (3) 42 (2) 110 (2)
Unspecified 21 (1) 26 (1) 47 (1)
No 2050 (83) 1893 (82) 3943 (82)
Missing 81 (3) 66 (3) 0.01b 147 (3)
Mental problems now Yes 334 (14) 298 (13) 632 (13)
No 2034 (82) 1912 (83) 3946 (83)
Missing 98 (4) 105 (5) 0.52b 203 (4)
Mental problems prior Yes 354 (14) 331 (14) 685 (14)
No 1730 (70) 1636 (71) 3366 (70)
Missing 382 (15) 348 (15) 0.9b 730 (15)
n (%), median [interquartile range]
p values not corrected for multiple testing
aMann-Whitney U test (non-parametric)
bChi-squared test
cWelch’s t-test
Table 3 Three, 12 and 24 month response rates
3 months 12 months 24 months
Group A Group B Group A Group B Group A Group B
Posted (n) 6112 5993 2548 2366 1752 1617
Response (n) 2466 2315 1873 1719 1527 1406
Response Rate (%) 40.3 38.6 73.5 72.7 87.2 87.0
Absolute difference (%) 1.7 0.9 0.2
95% CI 0.0 to 3.5 −1.7 to 3.4 −2.1 to 2.5
Relative Risk 1.03 1.03 1.02
95% CI 1.00 to 1.06 0.94 to 1.13 0.85 to 1.21
p 0.053 0.52 0.878
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We undertook this study before the Study Within a
Trial (SWAT) programme commenced [14, 23]. Our
study demonstrates that large scale SWATs examining
clinical outcomes can be undertaken. Our findings high-
light the potential impact of trial methodologies on
outcomes.
With the same response rate in the two groups, we
did not expect different answers to EQ-5D-3 L do-
mains. The reasons underlying the different answers
remain unclear. The extra questions may have resulted
in a different response group. Alternatively, the extra
questions may have caused the same group to respond
differently. We need to understand better the links
between questionnaire burden and the pattern of
answers.
Conclusions
In patients treated on an intensive care unit questionnaire
burden affected the findings from the same questionnaire.
This is a compelling reason to minimise the questionnaire
burden. Halving the number of questionnaire pages had
no effect on the return rate.
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Table 4 Three month questionnaire responses
Group A Group B
EuroQol 5 Dimension 3 Level (EQ-5D-3 L)
Valid Responses n = 2399 (97) n = 2263 (98)
Mobility
level 1 978 (41) 826 (37) p = 0.003a
level 2 1382 (58) 1407 (62)
level 3 39 (2) 30 (1)
Self Care
level 1 1656 (69) 1572 (69) p = 0.771a
level 2 687 (29) 648 (29)
level 3 56 (2) 43 (2)
Usual Activities
level 1 716 (30) 626 (28) p = 0.107a
level 2 1323 (55) 1254 (55)
level 3 360 (15) 383 (17)
Pain/Discomfort
level 1 785 (33) 742 (33) p = 0.986a
level 2 1386 (58) 1318 (58)
level 3 228 (10) 203 (9)
Anxiety/Depression
level 1 1409 (59) 1250 (55) p = 0.017a
level 2 836 (35) 864 (38)
level 3 154 (6) 149 (7)
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EuroQol Visual Analogue Scale (EQ VAS)
Valid Responses n = 2402 (97) n = 2244 (97)
EQ VAS Score 70 [50–80] 66 [50–80] p = 0.174
n (%), median [interquartile range]
aChi-square test comparing level 1 “No problems” with a single collapsed category combining level 2-“moderate” and level 3-“severe”
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